Development of an alarm symptom-based risk prediction score for localized oesophagogastric adenocarcinoma (VIOLA score)

Autor: Puhr, H.C., Puhr, R., Kuchling, D.A., Jahic, L., Takats, J., Reiter, T.J., Paireder, M., Jomrich, G., Schoppmann, S.F., Berghoff, A.S., Preusser, M., Ilhan-Mutlu, A.

Publikováno v: In ESMO Open August 2022 7(4)

Correction to: Association of family history with patient characteristics and prognosis in a large European gastroesophageal cancer cohort.

Autor: Puhr HC; Department of Medicine I, Division of Oncology, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria., Berchtold L; Department of Medicine I, Division of Oncology, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.;  Institute for Medical Statistics, Center for Medical Data Science, Medical University of Vienna, Vienna, Austria., Zingerle L; Department of Medicine I, Division of Oncology, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria., Felfernig M; Department of Medicine I, Division of Oncology, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria., Weissenbacher L; Department of Medicine I, Division of Oncology, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria., Jomrich G; Department of Surgery, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria., Asari R; Department of Surgery, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria., Schoppmann SF; Department of Surgery, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria., Prager GW; Department of Medicine I, Division of Oncology, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria., Bergen ES; Department of Medicine I, Division of Oncology, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria., Berghoff AS; Department of Medicine I, Division of Oncology, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria., Preusser M; Department of Medicine I, Division of Oncology, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria., Ilhan-Mutlu A; Department of Medicine I, Division of Oncology, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria. aysegul.ilhan@meduniwien.ac.at.

Publikováno v: Wiener klinische Wochenschrift [Wien Klin Wochenschr] 2024 Oct 18. Date of Electronic Publication: 2024 Oct 18.

Systemic inflammatory biomarkers as prognostic tools in patients with gastroesophageal adenocarcinoma.

Autor: Puhr HC; Division of Oncology, Department of Medicine I, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.; Christian Doppler Laboratory for Personalized Immunotherapy, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria., Weirauch CC; Division of Oncology, Department of Medicine I, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria., Selimi F; Division of Oncology, Department of Medicine I, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria., Oberreiter K; Division of Oncology, Department of Medicine I, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria., Dieterle MA; Division of Oncology, Department of Medicine I, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria., Jomrich G; Department of Surgery, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Vienna, Austria., Schoppmann SF; Department of Surgery, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Vienna, Austria., Prager GW; Division of Oncology, Department of Medicine I, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.; Christian Doppler Laboratory for Personalized Immunotherapy, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria., Berghoff AS; Division of Oncology, Department of Medicine I, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.; Christian Doppler Laboratory for Personalized Immunotherapy, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria., Preusser M; Division of Oncology, Department of Medicine I, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.; Christian Doppler Laboratory for Personalized Immunotherapy, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria., Ilhan-Mutlu A; Division of Oncology, Department of Medicine I, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria. aysegul.ilhan@meduniwien.ac.at.; Christian Doppler Laboratory for Personalized Immunotherapy, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria. aysegul.ilhan@meduniwien.ac.at.

Publikováno v: Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2023 Dec; Vol. 149 (19), pp. 17081-17091. Date of Electronic Publication: 2023 Sep 26.

Screening for oncogenic AF1q expression predicts disease recurrence in gastric cancer patients.

Autor: Gruber ES; Division of Visceral Surgery, Department of General Surgery, Medical University Vienna, Waehringer Guertel 18-20, 1090, Vienna, Vienna, Austria. elisabeth.s.gruber@meduniwien.ac.at., Oberhuber G; Department of Experimental and Animal Pathology, Clinical Institute of Pathology, Medical University Vienna, Waehringer Guertel 18-20, 1090, Vienna, Vienna, Austria.; PIZ - patho im zentrum GmbH, St. Poelten, Lower Austria, Austria., Schlederer M; Department of Experimental and Animal Pathology, Clinical Institute of Pathology, Medical University Vienna, Waehringer Guertel 18-20, 1090, Vienna, Vienna, Austria., Birner P; Department of Experimental and Animal Pathology, Clinical Institute of Pathology, Medical University Vienna, Waehringer Guertel 18-20, 1090, Vienna, Vienna, Austria., Jomrich G; Division of Visceral Surgery, Department of General Surgery, Medical University Vienna, Waehringer Guertel 18-20, 1090, Vienna, Vienna, Austria., Schoppmann SF; Division of Visceral Surgery, Department of General Surgery, Medical University Vienna, Waehringer Guertel 18-20, 1090, Vienna, Vienna, Austria., Tse W; Department of Medicine, School of Medicine, Case Western Reserve University, Cleveland, OH, USA.; Immune Oncology Program, Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH, USA., Kenner L; Department of Experimental and Animal Pathology, Clinical Institute of Pathology, Medical University Vienna, Waehringer Guertel 18-20, 1090, Vienna, Vienna, Austria. lukas.kenner@meduniwien.ac.at.; Unit of Laboratory Animal Pathology, University of Veterinary Medicine Vienna, Vienna, Austria. lukas.kenner@meduniwien.ac.at.; Christian Doppler Laboratory for Applied Metabolomics, Medical University Vienna, Vienna, Austria. lukas.kenner@meduniwien.ac.at.; Center for Biomarker Research in Medicine (CBmed), Graz, Styria, Austria. lukas.kenner@meduniwien.ac.at.

Publikováno v: Scientific reports [Sci Rep] 2024 Jul 10; Vol. 14 (1), pp. 15988. Date of Electronic Publication: 2024 Jul 10.

The Revised R Status is an Independent Predictor of Postresection Survival in Pancreatic Cancer After Neoadjuvant Treatment.

Autor: Leonhardt CS; Division of Visceral Surgery, Department of General Surgery, Medical University of Vienna, Vienna, Austria., Pils D; Division of Visceral Surgery, Department of General Surgery, Medical University of Vienna, Vienna, Austria., Qadan M; Department of Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA., Jomrich G; Division of Visceral Surgery, Department of General Surgery, Medical University of Vienna, Vienna, Austria., Assawasirisin C; Department of Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA., Klaiber U; Division of Visceral Surgery, Department of General Surgery, Medical University of Vienna, Vienna, Austria., Sahora K; Division of Visceral Surgery, Department of General Surgery, Medical University of Vienna, Vienna, Austria., Warshaw AL; Department of Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA., Ferrone CR; Department of Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA., Schindl M; Division of Visceral Surgery, Department of General Surgery, Medical University of Vienna, Vienna, Austria., Lillemoe KD; Department of Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA., Strobel O; Division of Visceral Surgery, Department of General Surgery, Medical University of Vienna, Vienna, Austria., Fernández-Del Castillo C; Department of Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA., Hank T; Division of Visceral Surgery, Department of General Surgery, Medical University of Vienna, Vienna, Austria.; Department of Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA.

Publikováno v: Annals of surgery [Ann Surg] 2024 Feb 01; Vol. 279 (2), pp. 314-322. Date of Electronic Publication: 2023 Apr 12.